Injectional interferon alpha‐2B vs Normal saline
Treatment discontinuation · men with chronic (≥ 12 months) Peyronie's disease (single plaque)
It is very uncertain whether injectional interferon alpha‐2B changes discontinuation from treatment compared with saline (very low certainty).
1 finding from 1 review
- RR 0.63 [0.22, 1.76]1 study · 117 participantsVery low